Isoflavones inhibit the activity of aromatase (CYP19), thus decreasing estrogen biosynthesis and producing antiestrogenic effects, important in the treatment of breast and prostate cancer [5]. This evidence concerns the gene CYP19A1 and prostate carcinoma.